BON NATURAL LIFE LTD-A (BON) Stock Fundamental Analysis

NASDAQ:BON • KYG144922047

1.59 USD
-0.07 (-4.22%)
At close: Feb 20, 2026
1.6001 USD
+0.01 (+0.64%)
After Hours: 2/20/2026, 8:19:34 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

BON gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. Both the profitability and financial health of BON have multiple concerns. BON is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • BON had positive earnings in the past year.
  • In the past year BON had a positive cash flow from operations.
  • BON had positive earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: BON reported negative operating cash flow in multiple years.
BON Yearly Net Income VS EBIT VS OCF VS FCFBON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M

1.2 Ratios

  • With a Return On Assets value of -2.34%, BON is not doing good in the industry: 62.65% of the companies in the same industry are doing better.
  • With a Return On Equity value of -3.47%, BON perfoms like the industry average, outperforming 44.58% of the companies in the same industry.
Industry RankSector Rank
ROA -2.34%
ROE -3.47%
ROIC N/A
ROA(3y)2.72%
ROA(5y)7.5%
ROE(3y)3.46%
ROE(5y)9.83%
ROIC(3y)N/A
ROIC(5y)N/A
BON Yearly ROA, ROE, ROICBON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

  • BON's Gross Margin of 20.78% is on the low side compared to the rest of the industry. BON is outperformed by 63.86% of its industry peers.
  • BON's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for BON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.96%
GM growth 5Y-6.16%
BON Yearly Profit, Operating, Gross MarginsBON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • BON does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BON has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, BON has more shares outstanding
  • The debt/assets ratio for BON is higher compared to a year ago.
BON Yearly Shares OutstandingBON Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
BON Yearly Total Debt VS Total AssetsBON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • BON has an Altman-Z score of 0.97. This is a bad value and indicates that BON is not financially healthy and even has some risk of bankruptcy.
  • BON's Altman-Z score of 0.97 is on the low side compared to the rest of the industry. BON is outperformed by 77.11% of its industry peers.
  • A Debt/Equity ratio of 0.19 indicates that BON is not too dependend on debt financing.
  • BON has a better Debt to Equity ratio (0.19) than 80.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 0.97
ROIC/WACCN/A
WACC8.62%
BON Yearly LT Debt VS Equity VS FCFBON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M

2.3 Liquidity

  • BON has a Current Ratio of 1.74. This is a normal value and indicates that BON is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of BON (1.74) is comparable to the rest of the industry.
  • A Quick Ratio of 1.61 indicates that BON should not have too much problems paying its short term obligations.
  • BON has a better Quick ratio (1.61) than 66.27% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.61
BON Yearly Current Assets VS Current LiabilitesBON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • BON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -96.73%.
  • BON shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -21.70%.
  • Measured over the past years, BON shows a small growth in Revenue. The Revenue has been growing by 0.49% on average per year.
EPS 1Y (TTM)-96.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114.33%
Revenue 1Y (TTM)-21.7%
Revenue growth 3Y-14.54%
Revenue growth 5Y0.49%
Sales Q2Q%-21.52%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue is expected to grow by 13.43% on average over the next years. This is quite good.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.82%
Revenue Next 2Y17.22%
Revenue Next 3Y15.15%
Revenue Next 5Y13.43%

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BON Yearly Revenue VS EstimatesBON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M 100M
BON Yearly EPS VS EstimatesBON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 50 100 150

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • BON is valuated rather expensively with a Price/Earnings ratio of 17.67.
  • BON's Price/Earnings ratio is a bit cheaper when compared to the industry. BON is cheaper than 65.06% of the companies in the same industry.
  • BON's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.99.
Industry RankSector Rank
PE 17.67
Fwd PE N/A
BON Price Earnings VS Forward Price EarningsBON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BON Per share dataBON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for BON!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BON NATURAL LIFE LTD-A

NASDAQ:BON (2/20/2026, 8:19:34 PM)

After market: 1.6001 +0.01 (+0.64%)

1.59

-0.07 (-4.22%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-23
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap9.81M
Revenue(TTM)18.67M
Net Income(TTM)-1.99M
Analysts0
Price TargetN/A
Short Float %0.51%
Short Ratio1.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.67
Fwd PE N/A
P/S 0.53
P/FCF N/A
P/OCF 69.53
P/B 0.17
P/tB 0.19
EV/EBITDA N/A
EPS(TTM)0.09
EY5.66%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.6
FCFYN/A
OCF(TTM)0.02
OCFY1.44%
SpS3.03
BVpS9.33
TBVpS8.29
PEG (NY)N/A
PEG (5Y)N/A
Graham Number4.35
Profitability
Industry RankSector Rank
ROA -2.34%
ROE -3.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.78%
FCFM N/A
ROA(3y)2.72%
ROA(5y)7.5%
ROE(3y)3.46%
ROE(5y)9.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.96%
GM growth 5Y-6.16%
F-Score3
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 919.08%
Cap/Sales 53.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.74
Quick Ratio 1.61
Altman-Z 0.97
F-Score3
WACC8.62%
ROIC/WACCN/A
Cap/Depr(3y)348.17%
Cap/Depr(5y)1058.3%
Cap/Sales(3y)19.2%
Cap/Sales(5y)18.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.7%
Revenue growth 3Y-14.54%
Revenue growth 5Y0.49%
Sales Q2Q%-21.52%
Revenue Next Year18.82%
Revenue Next 2Y17.22%
Revenue Next 3Y15.15%
Revenue Next 5Y13.43%
EBIT growth 1Y-186.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y101.83%
OCF growth 3YN/A
OCF growth 5Y-44.35%

BON NATURAL LIFE LTD-A / BON FAQ

Can you provide the ChartMill fundamental rating for BON NATURAL LIFE LTD-A?

ChartMill assigns a fundamental rating of 2 / 10 to BON.


Can you provide the valuation status for BON NATURAL LIFE LTD-A?

ChartMill assigns a valuation rating of 1 / 10 to BON NATURAL LIFE LTD-A (BON). This can be considered as Overvalued.


How profitable is BON NATURAL LIFE LTD-A (BON) stock?

BON NATURAL LIFE LTD-A (BON) has a profitability rating of 2 / 10.